Spinal cord stimulation and physical therapy have helped a man paralyzed since 2013 regain his ability to stand and walk with assistance. The results, achieved in a research collaboration between Mayo Clinic and UCLA, are reported in Nature Medicine.
With an implanted stimulator turned on, the man, Jered Chinnock, was able to step with a front-wheeled walker while trainers provided occasional assistance. He made 113 rehabilitation visits to Mayo Clinic over a year, and achieved milestones during individual sessions:
- Total distance: 111 yards (102 meters) — about the length of a football field
- Total number of steps: 331
- Total minutes walking with assistance:16 minutes
- Step speed: 13 yards per minute (0.20 meters per second)
“What this is teaching us is that those networks of neurons below a spinal cord injury still can function after paralysis,” says Kendall Lee, M.D., Ph.D., co-principal investigator, neurosurgeon and director of Mayo Clinic’s Neural Engineering Laboratories.
In the study, Chinnock’s spinal cord was stimulated by an implanted electrode, enabling neurons to receive the signal that he wanted to stand or step.
“Now I think the real challenge starts, and that’s understanding how this happened, why it happened, and which patients will respond, says Kristin Zhao, Ph.D., co-principal investigator and director of Mayo Clinic’s Assistive and Restorative Technology Laboratory.
Currently, as a safety precaution, Chinnock takes steps only under the supervision of the research team.
Chinnock, now 29, injured his spinal cord at the thoracic vertebrae in the middle of his back in a snowmobile accident in 2013. He was diagnosed with a complete loss of function below the spinal cord injury, meaning he could not move or feel anything below the middle of his torso.
In the study, which began in 2016, Chinnock participated in 22 weeks of physical therapy and then had an electrode surgically implanted by Dr. Lee and his Mayo Clinic neurosurgery team.
The implant sits in the epidural space — the outermost part of the spinal canal — at a specific location below the injured area. The electrode connects to a pulse generator device under the skin of Chinnock’s abdomen and communicates wirelessly with an external controller. Mayo Clinic received permission from the U.S. Food and Drug Administration to use the device for a condition not covered by its FDA-approved label.
The research team then tried to determine if Chinnock could stand and walk with assistance. During 113 rehabilitation sessions, the researchers adjusted stimulation settings, trainer assistance, harness support and speed of the treadmill to allow him maximum independence.
The research demonstrated that Chinnock was able to walk over ground using a front-wheeled walker and step on a treadmill placing his arms on support bars to help with balance. However, when stimulation was off, Chinnock remained paralyzed.
In the first week, Chinnock used a harness to lower his risk of falling and to provide upper body balance. Trainers were positioned at his knees and hips to help him stand, swing his legs and shift his weight. Because Chinnock did not regain sensation, he initially used mirrors to view his legs, and trainers described leg position, movement and balance. By week 25, he did not need a harness, and trainers offered only occasional help. By the end of the study period, he learned to use his entire body to transfer weight, maintain balance and propel forward, requiring minimal verbal cues and periodic glances at his legs.
The Latest on: Spinal cord stimulation
via Google News
The Latest on: Spinal cord stimulation
- Asia Pacific Spinal Cord Stimulation Devices Market Estimated to Grow with a CAGR of 9.3%, 2019-2025 - ResearchAndMarkets.comon November 18, 2019 at 4:11 pm
The "Asia Pacific Spinal Cord Stimulation Devices Market 2019-2025)" report has been added to ResearchAndMarkets.com's offering. The Asia Pacific Spinal Cord Stimulation Devices Market is expected to ...
- Spinal-cord stimulator 'really promising': Survivor moves legs for first time since Humboldt bus crashon November 15, 2019 at 10:36 pm
They’re just sort of fancy pacemakers Over the past two years, Darrow’s research team has conducted the same type of experimental procedure, in which surgeons implant a stimulator in the spine. The ...
- Global Spinal Cord Stimulation Devices Market Expected To Witness An Imperishable Growth Over 2029on November 14, 2019 at 9:24 pm
Nov 15, 2019 (WiredRelease via COMTEX) -- The industry analysis report identifying hidden opportunities of Spinal Cord Stimulation Devices Market, which will help to expand operations in the existing ...
- The translational landscape in spinal cord injury: focus on neuroplasticity and regenerationon November 14, 2019 at 1:00 pm
Unprecedented long-distance axon regeneration, cell replacement and relay formation have been achieved using spinal cord-derived neural stem cell grafts combined with growth factors. Neuromodulation ...
- Spinal Cord Stimulation System Market 2019 : Global Industry Size, Share, Growth, Forecasts to 2026on November 13, 2019 at 9:44 pm
Nov 14, 2019 (Market Prediction via COMTEX) -- A new research report titled “Global Spinal Cord Stimulation System market” successfully exhibits the complete scenario of the global and an individual ...
- Spinal cord stimulator provides Tonawanda man pain relief without opioidson November 13, 2019 at 10:46 am
"It was just pain all the time," Marra said. "I'd wake up in pain. I'd go to bed in pain." After multiple failed back surgery, he was left with few options, until a doctor recommended a spinal cord ...
- Spinal Cord Stimulation Market Size to Worth $4,236.2 Million Forecast by 2026on November 8, 2019 at 2:52 am
Spinal Cord Stimulation Market Overview: The Global Spinal Cord Stimulation Market is expected to gain from increasing per capita income. Recently Fortune Business insights, published a report, titled ...
- FDA Approves Unique Spinal Cord Stimulation System for Chronic Painon November 8, 2019 at 1:00 am
The Omnia system has conditional full body MRI approval. The Food and Drug Administration (FDA) has approved the Senza Omnia Spinal Cord Stimulation (SCS) System (Nevro) for the treatment of chronic ...
- When a spinal cord stimulator fails, the device, the body, or the mind may be to blameon November 7, 2019 at 12:51 am
For many people who suffer chronic, debilitating pain in the lower back or limbs, the implantation of a spinal cord stimulator can be a life-changer. By delivering electrical pulses that interrupt ...
via Bing News